BET inhibitors have been widely studied to downregulate MYC in myc-overexpressed cancers and to have anticancer effects.16,35 In this paper, we demonstrated that BETi exhibited antitumor effects by downregulating endogenous MYC in PanNET cells in vitro and in vivo. The gene discussed is MYC; the disease is cancer.